{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:28:38Z","timestamp":1793327318860,"version":"4.5.0"},"reference-count":81,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T00:00:00Z","timestamp":1653523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Isotretinoin (ISO) is an oral prescription-only retinoid, well known for its acne-treating effect. However, it affects a substantial number of human cell types, causing a broad spectrum of adverse effects. The purpose of this study is to establish the isotretinoin therapy adverse events among human clinical trials and their prevalence. Two authors (J.K., J.L.) systematically performed the literature review and assessment from December 2021\u2013February 2022. Three databases (PubMed, ClinicalTrials, and Cochrane Library) were searched using the following terms: \u201cisotretinoin acne vulgaris\u201d for published studies in English from 1980\u20132021. Finally, 25 randomized controlled clinical trials (RCTs) and five open-label clinical trials provided 3274 acne vulgaris suffering patients. Isotretinoin therapy affects almost all of the systems in the human body, causing numerous adverse events. However, they mainly concern mild mucocutaneous conditions (severe cases are rare) and represent individual responses to a drug. In addition, all adverse events are reversible and can be avoided by specific preparations.<\/jats:p>","DOI":"10.3390\/ijerph19116463","type":"journal-article","created":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T08:50:22Z","timestamp":1653555022000},"page":"6463","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Adverse Events in Isotretinoin Therapy: A Single-Arm Meta-Analysis"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4019-851X","authenticated-orcid":false,"given":"Jan","family":"Kapa\u0142a","sequence":"first","affiliation":[{"name":"Medical Faculty, University of Warmia and Mazury in Olsztyn, 10-719 Olsztyn, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3493-2047","authenticated-orcid":false,"given":"Julia","family":"Lewandowska","sequence":"additional","affiliation":[{"name":"Medical Faculty, University of Warmia and Mazury in Olsztyn, 10-719 Olsztyn, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waldemar","family":"Placek","sequence":"additional","affiliation":[{"name":"Department of Dermatology Sexually Transmitted Diseases and Clinical Immunology, University of Warmia and Mazury in Olsztyn, 10-719 Olsztyn, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8372-0438","authenticated-orcid":false,"given":"Agnieszka","family":"Owczarczyk-Saczonek","sequence":"additional","affiliation":[{"name":"Department of Dermatology Sexually Transmitted Diseases and Clinical Immunology, University of Warmia and Mazury in Olsztyn, 10-719 Olsztyn, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,26]]},"reference":[{"key":"ref_1","unstructured":"National Center for Biotechnology Information (2022, February 28). PubChem Compound Summary for CID 5282379, Isotretinoin, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Isotretinoin."},{"key":"ref_2","unstructured":"Pile, H.D., and Sadiq, N.M. (2022, February 28). Isotretinoin, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK525949\/."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.abd.2020.09.001","article-title":"Consensus on the use of oral isotretinoin in dermatology\u2014Brazilian Society of Dermatology","volume":"95","author":"Bagatin","year":"2020","journal-title":"An. Bras. Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/tera.1420360110","article-title":"Developmental effects of isotretinoin and 4-oxo-isotretinoin: The role of metabolism in teratogenicity","volume":"36","author":"Kochhar","year":"1987","journal-title":"Teratology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.1067\/mjd.2001.113720","article-title":"Teratogenicity of isotretinoin revisited: Species variation and the role of all-trans-retinoic acid","volume":"45","author":"Nau","year":"2001","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/ijd.15425","article-title":"The \u201cMaskne\u201d microbiome\u2014Pathophysiology and therapeutics","volume":"60","author":"Teo","year":"2021","journal-title":"Int. J. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1111\/jocd.14530","article-title":"The course of acne in healthcare workers during the COVID-19 pandemic and evaluation of possible risk factors","volume":"20","year":"2021","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/ebmed-2017-110668","article-title":"Rating the certainty in evidence in the absence of a single estimate of effect","volume":"22","author":"Murad","year":"2017","journal-title":"Evid. Based Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction\u2014GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"ref_11","first-page":"13","article-title":"An Open-label, Phase IV Study Evaluating Lidose-isotretinoin Adminis-tered without Food in Patients with Severe Recalcitrant Nodular Acne: Low Relapse Rates Observed Over the 104-week Post-treatment Period","volume":"12","author":"Segal","year":"2019","journal-title":"J. Clin. Aesthetic Dermatol."},{"key":"ref_12","unstructured":"(2022, February 28). Clinical Trials, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT00975143?term=isotretinoin&rslt=With&cond=Acne+Vulgaris&draw=2&rank=2&view=results."},{"key":"ref_13","unstructured":"(2022, February 28). Clinical Trials, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT01474590?term=isotretinoin&rslt=With&cond=Acne+Vulgaris&draw=2&rank=4&view=results."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10103-020-03113-z","article-title":"Isotretinoin plus 420 nm intense pulsed light versus isotretinoin alone for the treatment of acne vulgaris: A randomized, controlled study of efficacy, safety, and patient satisfaction in Chinese subjects","volume":"36","author":"Li","year":"2021","journal-title":"Lasers Med. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1097\/DSS.0000000000001546","article-title":"Concomitant Use of 1,550-nm Nonablative Fractional Laser with Low-Dose Isotretinoin for the Treatment of Acne Vulgaris in Asian Patients: A Randomized Split-Face Controlled Study","volume":"44","author":"Xia","year":"2018","journal-title":"Dermatol. Surg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/lsm.23356","article-title":"Combined low-dose isotretinoin and pulsed dye laser versus standard-dose isotretinoin in the treatment of inflammatory acne","volume":"53","author":"Ibrahim","year":"2021","journal-title":"Lasers Surg. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/jdv.12170","article-title":"Isotretinoin 5 mg daily for low-grade adult acne vulgaris\u2014A placebo-controlled, randomized double-blind study","volume":"28","author":"Rademaker","year":"2014","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/dth.12213","article-title":"Analysis of clinical efficacy, side effects, and laboratory changes among patients with acne vulgaris receiving single versus twice daily dose of oral isotretinoin","volume":"28","author":"Ahmad","year":"2015","journal-title":"Dermatol. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/bjd.13191","article-title":"A treatment for severe nodular acne: A randomized investigator-blinded, controlled, noninferiority trial comparing fixed-dose adapalene\/benzoyl peroxide plus doxycycline vs. oral isotretinoin","volume":"171","author":"Tan","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2340\/00015555-0211","article-title":"Clinical and microbiological comparisons of isotretinoin vs. tetracycline in acne vulgaris","volume":"87","author":"Oprica","year":"2007","journal-title":"Acta Derm. Venereol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"688","DOI":"10.4103\/0378-6323.86482","article-title":"Oral isotretinoin in different dose regimens for acne vulgaris: A randomized comparative trial","volume":"77","author":"Agarwal","year":"2011","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-4632.2009.04232.x","article-title":"Influence of isotretinoin on nasal mucociliary clearance and lung function in patients with acne vulgaris","volume":"49","author":"Gorpelioglu","year":"2010","journal-title":"Int. J. Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00403-007-0777-2","article-title":"Treatment of acne with intermittent and conventional isotretinoin: A randomized, controlled multicenter study","volume":"299","author":"Akman","year":"2007","journal-title":"Arch. Dermatol. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1365-2133.2010.10152.x","article-title":"Effectiveness of conventional, low-dose and intermittent oral isotretinoin in the treatment of acne: A randomized, controlled comparative study","volume":"164","author":"Lee","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1365-4632.2004.02072.x","article-title":"Vitamin E does not reduce the side-effects of isotretinoin in the treatment of acne vulgaris","volume":"44","author":"Kus","year":"2005","journal-title":"Int. J. Dermatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/j.1468-3083.2006.01784.x","article-title":"The effectiveness of intermittent isotretinoin treatment in mild or moderate acne","volume":"20","author":"Kaymak","year":"2006","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jaad.2004.04.032","article-title":"Effect of a single course of isotretinoin therapy on bone mineral density in adolescent patients with severe, recalcitrant, nodular acne","volume":"51","author":"DiGiovanna","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1067\/mjd.2000.110391","article-title":"Concomitant administration of vitamin E does not change the side effects of isotretinoin as used in acne vulgaris: A randomized trial","volume":"43","author":"Strauss","year":"2000","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1468-3083.1998.tb00763.x","article-title":"Medium dose isotretinoin for the treatment of acne","volume":"11","author":"Hermes","year":"1998","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000045270","article-title":"Hemodialysis-related nodulocystic acne treated with isotretinoin","volume":"81","author":"Lin","year":"1999","journal-title":"Nephron"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1067\/mjd.2001.115966","article-title":"Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoin","volume":"45","author":"Strauss","year":"2001","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0190-9622(84)80100-0","article-title":"Isotretinoin therapy for acne: Results of a multicenter dose-response study","volume":"10","author":"Strauss","year":"1984","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-4362.1985.tb05775.x","article-title":"Isotretinoin and tetracycline in the management of severe nodulocystic acne","volume":"24","author":"Lester","year":"1985","journal-title":"Int. J. Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0190-9622(82)70066-0","article-title":"Comparative effect of isotretinoin and etretinate on acne and sebaceous gland secretion","volume":"6","author":"Goldstein","year":"1982","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2133.1983.tb03973.x","article-title":"A dose-response study of I3-cis-retinoic acid in acne vulgaris","volume":"108","author":"Jones","year":"1983","journal-title":"Br. J. Dermatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1001\/jamadermatol.2013.6746","article-title":"High-Dose Isotretinoin Treatment and the Rate of Retrial, Relapse, and Adverse Effects in Patients with Acne Vulgaris","volume":"149","author":"Blasiak","year":"2013","journal-title":"JAMA Dermatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"6974045","DOI":"10.1155\/2018\/6974045","article-title":"Is Oral Omega-3 Effective in Reducing Mucocutaneous Side Effects of Isotretinoin in Patients with Acne Vulgaris?","volume":"2018","author":"Mirnezami","year":"2018","journal-title":"Dermatol. Res. Pract."},{"key":"ref_38","first-page":"224","article-title":"Use of 13-cis-retinoic acid in cystic acne","volume":"129","author":"Kanigsberg","year":"1983","journal-title":"Can. Med. Assoc. J."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0190-9622(80)80074-0","article-title":"The treatment of severe cystic acne with 13-cis-retinoic acid: Evaluation of sebum production and the clinical response in a multiple-dose trial","volume":"3","author":"Farrell","year":"1980","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000249803","article-title":"Dose-response relationship in isotretinoin therapy for conglobate acne","volume":"167","author":"Stijnen","year":"1983","journal-title":"Dermatologica"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/15569527.2021.1922434","article-title":"Evaluation of the changes in sebum, moisturization and elasticity in acne vulgaris patients receiving systemic isotretinoin treatment","volume":"40","author":"Gencebay","year":"2021","journal-title":"Cutan. Ocul. Toxicol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/17512433.2020.1796637","article-title":"The use of isotretinoin for acne\u2014An update on optimal dosing, surveillance, and adverse effects","volume":"13","author":"Bagatin","year":"2020","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/jocd.12800","article-title":"Effects of isotretinoin on the hair cycle","volume":"18","year":"2019","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1590\/abd1806-4841.20163817","article-title":"Paronychia and granulation tissue formation during treatment with isotretinoin","volume":"91","author":"Figueiras","year":"2016","journal-title":"An. Bras. Dermatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.joco.2018.06.005","article-title":"Evaluation of the effects of isotretinoin for treatment of acne on corneal sensitivity","volume":"30","author":"Fouladgar","year":"2018","journal-title":"J. Curr. Ophthalmol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/ICO.0b013e318183a396","article-title":"Conjunctival impression cytology, ocular surface, and tear-film changes in patients treated with systemic isotretinoin","volume":"28","author":"Karalezli","year":"2009","journal-title":"Cornea"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/15569527.2016.1265549","article-title":"The long-term effect of oral isotretinoin therapy on macula ganglion cell complex thickness","volume":"36","author":"Demirok","year":"2017","journal-title":"Cutan. Ocul. Toxicol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2310\/7750.2013.13168","article-title":"Effect of Oral Isotretinoin Treatment on Retinal Nerve Fiber Layer Thickness","volume":"18","author":"Ucak","year":"2014","journal-title":"J. Cutan. Med. Surg."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/15569527.2021.1914075","article-title":"Choroidal vascular changes in acne patients under isotretinoin treatment","volume":"40","author":"Gediz","year":"2021","journal-title":"Cutan. Ocul. Toxicol."},{"key":"ref_50","unstructured":"Bhutta, B.S., and Hafsi, W. (2022, February 28). Cheilitis, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470592\/."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e14640","DOI":"10.1111\/dth.14640","article-title":"Evaluation of oral isotretinoin effects on hearing system in patients with acne vulgaris: Reversible or not?","volume":"34","author":"Kemeriz","year":"2021","journal-title":"Dermatol. Ther."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"S188","DOI":"10.1067\/mjd.2001.113719","article-title":"Analysis of common side effects of isotretinoin","volume":"45","author":"McLane","year":"2001","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00213-011-2611-y","article-title":"Influence of isotretinoin on hippocampal-based learning in human subjects","volume":"221","author":"Ormerod","year":"2012","journal-title":"Psychopharmacology"},{"key":"ref_54","first-page":"23","article-title":"Effects of oral isotretinoin on serum folic acid levels","volume":"11","author":"Javanbakht","year":"2012","journal-title":"J. Drugs Dermatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/09546630701846079","article-title":"Plasma homocysteine level is elevated in patients on isotretinoin therapy for cystic acne: A prospective controlled study","volume":"19","author":"Polat","year":"2008","journal-title":"J. Dermatol. Treat."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1111\/j.1365-4632.2011.05027.x","article-title":"Effect of isotretinoin treatment on plasma holotranscobalamin, vitamin B12, folic acid, and homocysteine levels: Non-controlled study","volume":"50","author":"Karadag","year":"2011","journal-title":"Int. J. Dermatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1365-4362.2001.00146.x","article-title":"Elevated plasma homocysteine levels in patients on isotretinoin therapy for cystic acne","volume":"40","author":"Schulpis","year":"2001","journal-title":"Int. J. Dermatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1468-3083.2011.04089.x","article-title":"Isotretinoin has no negative effect on attention, executive function and mood","volume":"26","author":"Ergun","year":"2012","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-4632.2011.05334.x","article-title":"Mood changes, depression and suicide risk during isotretinoin treatment: A prospective study","volume":"52","year":"2013","journal-title":"Int. J. Dermatol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-4632.2009.03806.x","article-title":"Comparison of depression, anxiety and life quality in acne vulgaris patients who were treated with either isotretinoin or topical agents","volume":"48","author":"Kaymak","year":"2009","journal-title":"Int. J. Dermatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/09546630903164909","article-title":"Evaluation of depressive symptoms in acne patients treated with isotretinoin","volume":"20","year":"2009","journal-title":"J. Dermatol. Treat."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/j.1468-3083.2009.03313.x","article-title":"Depressive symptoms and suicidal ideation during isotretinoin treatment: A 12-week follow-up study of male Finnish military conscripts","volume":"23","author":"Rehn","year":"2009","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/09546630410027472","article-title":"A pilot study evaluating anxiety and depressive scores in acne patients treated with isotretinoin","volume":"15","author":"Ferahbas","year":"2004","journal-title":"J. Dermatol. Treat."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0190-9622(87)70166-2","article-title":"Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin","volume":"17","author":"Rubinow","year":"1987","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1046\/j.1440-0960.2002.00612.x","article-title":"Prospective study of depressive symptoms and quality of life in acne vulgaris patients treated with isotretinoin compared to antibiotic and topical therapy","volume":"43","author":"Ng","year":"2002","journal-title":"Australas. J. Dermatol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/archderm.141.5.557","article-title":"Isotretinoin therapy and mood changes in adolescents with moderate to severe acne: A cohort study","volume":"141","author":"Chia","year":"2005","journal-title":"Arch. Dermatol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000367687","article-title":"The effect of isotretinoin on retinol-binding protein 4, leptin, adiponectin and insulin resistance in acne vulgaris patients","volume":"230","author":"Karadag","year":"2015","journal-title":"Dermatology"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"294","DOI":"10.5114\/pdia.2016.56928","article-title":"Effects of isotretinoin on body mass index, serum adiponectin, leptin, and ghrelin levels in acne vulgaris patients","volume":"33","author":"Cemil","year":"2016","journal-title":"Postepy Dermatol. Allergol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Karaosmano\u011flu, N., and M\u00fclko\u011flu, C. (2020). Analysis of musculoskeletal side effects of oral Isotretinoin treatment: A cross-sectional study. BMC Musculoskelet. Disord., 21.","DOI":"10.1186\/s12891-020-03656-w"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1007\/s00198-015-3158-2","article-title":"A double-blind, randomized, Phase III, multicenter study in 358 pediatric subjects receiving isotretinoin therapy demonstrates no effect on pediatric bone mineral density","volume":"26","author":"Hoover","year":"2015","journal-title":"Osteoporos. Int."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/archderm.135.8.961","article-title":"Bone densities in patients receiving isotretinoin for cystic acne","volume":"135","author":"Leachman","year":"1999","journal-title":"Arch. Dermatol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/000155598441837","article-title":"Oral isotretinoin therapy in severe acne induces transient suppression of biochemical markers of bone turnover and calcium homeostasis","volume":"78","author":"Kindmark","year":"1998","journal-title":"Acta Derm. Venereol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1097\/01.smj.0000223658.00852.d8","article-title":"An adolescent with abdominal pain taking isotretinoin for severe acne","volume":"99","author":"Greene","year":"2006","journal-title":"South. Med. J."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MEG.0000000000000496","article-title":"Does exposure to isotretinoin increase the risk for the development of inflammatory bowel disease? A meta-analysis","volume":"28","author":"Lee","year":"2016","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1001\/jamadermatol.2013.1344","article-title":"Isotretinoin and risk for inflammatory bowel disease: A nested case-control study and meta-analysis of published and unpublished data","volume":"149","author":"Etminan","year":"2013","journal-title":"JAMA Dermatol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/07853890701753664","article-title":"Stevens-Johnson syndrome: Pathogenesis, diagnosis, and management","volume":"40","author":"Hazin","year":"2008","journal-title":"Ann. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.rbmo.2013.04.010","article-title":"Decreased ovarian reserve in female Sprague\u2013Dawley rats induced by isotretinoin (retinoic acid) exposure","volume":"27","author":"Abali","year":"2013","journal-title":"Reprod. Biomed. Online"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3109\/09513590.2013.860118","article-title":"The effects of isotretinoin on the ovarian reserve of females with acne","volume":"30","year":"2014","journal-title":"Gynecol. Endocrinol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000371551","article-title":"The effect of isotretinoin on ovarian reserve based on hormonal parameters, ovarian volume, and antral follicle count in women with acne","volume":"79","author":"Aksoy","year":"2015","journal-title":"Gynecol. Obstet. Investig."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/15569527.2014.888079","article-title":"Evaluation of ovarian reserve and function in female patients treated with oral isotretinoin for severe acne: An exploratory study","volume":"34","author":"Erden","year":"2015","journal-title":"Cutan. Ocul. Toxicol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3109\/15569527.2015.1119839","article-title":"The effect of systemic isotretinoin on male fertility","volume":"35","author":"Kartal","year":"2016","journal-title":"Cutan. Ocul. Toxicol."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/11\/6463\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:18:59Z","timestamp":1760138339000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/11\/6463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,26]]},"references-count":81,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["ijerph19116463"],"URL":"https:\/\/doi.org\/10.3390\/ijerph19116463","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,26]]}}}